Ozempic (Semaglutide)
$220.00Ozempic (semaglutide) is an established once-weekly GLP-1 analog that effectively regulates blood sugar and slows digestion to promote sustained weight loss and cardiovascular health.
Why Choose Ozempic?
Proven worldwide track record for consistent glucose management, appetite reduction, and cardiovascular risk reduction in adults.
How to Use
Administer once weekly on the same day each week, subcutaneously in the abdomen, thigh, or upper arm. Dose escalation follows standard 4-week increments.
Safety Information
Inform your healthcare provider if you have kidney problems, diabetic retinopathy, or a history of pancreatitis before starting treatment.
Potential Side Effects
Nausea, vomiting, diarrhea, abdominal pain, and constipation are the most frequently reported side effects, typically transient.
Product Facts
| Generic Name | Semaglutide |
| Brand Name | Ozempic |
| Type of Medication | GLP-1 Receptor Agonist |
| FDA Approval Date | December 5, 2017 |
| Indications | Indicated to improve glycemic control in adults with type 2 diabetes mellitus and reduce cardiovascular risk. |
| Dosage Forms | Multi-dose pre-filled pen injector delivering 0.25 mg, 0.5 mg, 1 mg, or 2 mg |
| Administration | Once weekly subcutaneous injection |
| Special Precautions | Contraindicated in patients with MTC or MEN 2 syndrome. Monitor renal function in patients reporting severe adverse GI reactions. |
| Drug Interactions | Delays gastric emptying; caution with oral drugs requiring rapid gastrointestinal absorption. |
| Use in Specific Populations | Discontinue at least 2 months before a planned pregnancy. Safety in pediatric patients has not been established. |
| Prescription | Prescription Required |
| Manufacturer | Novo Nordisk |
How to Buy
Choose your required pen strength, proceed to secure checkout, and receive your authentic medication delivered quickly with tracking.